The Market Reports

Synopsis
The global market for Diagnostics PCR was estimated to be worth US$ 661 million in 2024 and is forecast to a readjusted size of US$ 978 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
PCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.
The diagnostics PCR market is experiencing significant growth due to the increasing prevalence of infectious diseases, including COVID-19, influenza, tuberculosis, and sexually transmitted infections. The growing demand for rapid, accurate, and early diagnosis of diseases has made PCR an essential tool in clinical settings. Advances in PCR technology—such as real-time PCR (qPCR), multiplex PCR, and digital PCR—have further improved sensitivity and efficiency, leading to broader adoption in hospitals, clinics, and research institutions. Moreover, government initiatives to improve diagnostic infrastructure and the expansion of personalized medicine are also fueling market demand for PCR-based tests.
Despite its advantages, the diagnostics PCR market faces several challenges. High equipment costs and the need for skilled personnel can limit access in low-resource settings, particularly in developing countries. Moreover, false positives or negatives caused by sample contamination, reagent issues, or improper protocols can compromise the reliability of results. Intellectual property constraints and limited reimbursement policies in some regions also pose barriers to market growth. Furthermore, competition from alternative diagnostic methods, such as isothermal amplification and CRISPR-based detection, may gradually erode PCR’s dominance in certain applications.
Emerging trends in the diagnostics PCR market include the development of point-of-care PCR devices that offer portable, fast, and user-friendly solutions for decentralized testing. Integration of PCR systems with digital health technologies and artificial intelligence is improving workflow efficiency, result interpretation, and patient management. Companies are also investing in multiplex PCR assays capable of detecting multiple pathogens in a single test, which is particularly useful for respiratory panels. Additionally, the market is shifting toward automation and high-throughput systems to meet increasing diagnostic demands in both routine and outbreak scenarios.
Global Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent.
This report aims to provide a comprehensive presentation of the global market for Diagnostics PCR, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diagnostics PCR by region & country, by Type, and by Application.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Diagnostics PCR cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Diagnostics PCR market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostics PCR.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
Danaher
Hangzhou Bioer
Analytik Jena
Techne
Biosynex
Eppendorf
Tianlong Technology
Beijing Tiangen
Hongshi Medical
Suzhou Yarui Bio
Takara Bio
Bioneer
Segment by Type
Real-Time PCR
Digital PCR
Traditional PCR Machine
Other
Segment by Application
Hospital
Independent Laboratories
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diagnostics PCR manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diagnostics PCR in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diagnostics PCR in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index